Doxazosin
- Product NDC
- 23155-092
- Requested package NDC
- 23155-092-01
- 11-digit product format
- 231550092
- Labeler code
- 23155
- Product ID
- 23155-092_cf1c14bc-a5cc-4800-9ec8-d5fbe267c43c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Application
- ANDA205210
- Marketing category
- ANDA
- Marketing start
- 2018-02-13
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 23155-092 | 23155-092-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205210-001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | |
| A205210-002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | |
| A205210-003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | |
| A205210-004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A205210-001 | AB |
| A205210-002 | AB |
| A205210-003 | AB |
| A205210-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-001 | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET / ORAL | AB | 2018-02-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-002 | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET / ORAL | AB | 2018-02-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-003 | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET / ORAL | AB | 2018-02-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-004 | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET / ORAL | AB | 2018-02-13 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A205210-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205210-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205210-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205210-004 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A205210-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205210-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205210-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205210-004 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A205210-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205210-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205210-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205210-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A205210-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205210-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205210-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205210-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205210-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205210-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205210-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205210-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205210-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205210-004 | AB | 1 | 03ed91905a0d… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXAZOSIN MESYLATE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86P6PQK0MU | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7991373e-8a62-47f9-b4fb-90573485af4e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 07a517fc-5845-3816-0f81-0a121804ec9e | Product name | 6 | 20250107 |
| 171dd63c-7eea-ede4-c010-4c25ba0a1087 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23155-092-01 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-092-01 | EA - Each | 23155-092 | b0537b97-47c5-4deb-b1cc-cff18027c335 | 1 | 2019-04-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | dcaf1417-8849-47f3-b400-e41dd8e9ba18 | 2026-10-08 | Warnings, Adverse reactions | 205210 ANDA205210 |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 1e2f83a4-e800-4533-9d9a-15ea10d1cf92 | 2026-09-16 | Warnings, Adverse reactions | 205210 ANDA205210 |
| Doxazosin | DOXAZOSIN | Golden State Medical Supply, Inc. | 54eeef3d-c906-37e7-e063-6294a90afca2 | 2026-06-23 | Warnings, Adverse reactions | 205210 ANDA205210 |
| Doxazosin | DOXAZOSIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7991373e-8a62-47f9-b4fb-90573485af4e | 2024-07-04 | Warnings, Adverse reactions | 205210 ANDA205210 23155-092-01 23155-092 23155009201 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197625 | doxazosin mesylate 1 MG Oral Tablet | PSN | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197627 | doxazosin mesylate 4 MG Oral Tablet | PSN | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197628 | doxazosin mesylate 8 MG Oral Tablet | PSN | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197625 | doxazosin 1 MG Oral Tablet | SCD | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197627 | doxazosin 4 MG Oral Tablet | SCD | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197628 | doxazosin 8 MG Oral Tablet | SCD | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197625 | doxazosin (as doxazosin mesylate) 1 MG Oral Tablet | SY | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197627 | doxazosin (as doxazosin mesylate) 4 MG Oral Tablet | SY | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
| 197628 | doxazosin (as doxazosin mesylate) 8 MG Oral Tablet | SY | 7991373e-8a62-47f9-b4fb-90573485af4e | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 23155-092-01 | 23155009201 | 100 TABLET in 1 BOTTLE (23155-092-01) | 100 tablet | 2018-02-13 | 0000-00-00 | No | No | Current |